IL10 and cerebral infarction: MSCs have been shown to decrease proinflammatory cytokine gene expression in experimental acute lung injury [31,32], myocardial infarction [33] and acute renal failure [34] and to upregulate IL-10 expression in rat models of myocardial infarction and cerebral infarction [50,51].